<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RXRX
Recursion Pharmaceuticals
$
()


  • Recursion Pharmaceuticals call volume above normal and directionally bullish

    12/3/2024 - 13:45pm
  • Recursion announces first patient dosed in Phase 1/2 trial of REC-1245

    12/3/2024 - 08:36am
  • Unusually active option classes on open December 2nd

    12/2/2024 - 09:40am
  • Cathie Wood's ARK Investment buys 383K shares of Recursion Pharmaceuticals today

    11/20/2024 - 20:03pm
  • Unusually active option classes on open November 20th

    11/20/2024 - 09:40am
  • Recursion, Exscientia officially combine to advance drug discovery

    11/20/2024 - 07:14am
  • Recursion Pharmaceuticals call volume above normal and directionally bullish

    11/19/2024 - 12:25pm
  • Recursion, Exscientia shareholders approve proposed combination

    11/13/2024 - 09:10am
  • Closing Bell Movers: AppLoving up 29% after Q3 earnings beat

    11/6/2024 - 19:26pm
  • Recursion Pharmaceuticals reports Q3 EPS (34c), consensus (35c)

    11/6/2024 - 17:43pm
  • Cathie Wood's ARK Investment buys 106K shares of Recursion Pharmaceuticals today

    11/4/2024 - 20:20pm
  • Cathie Wood's ARK Investment buys 729K shares of Recursion Pharmaceuticals today

    10/31/2024 - 20:11pm
  • Cathie Wood's ARK Investment buys 331K shares of Recursion Pharmaceuticals today

    10/30/2024 - 20:11pm
  • Recursion Pharmaceuticals call volume above normal and directionally bullish

    10/23/2024 - 13:45pm
  • Recursion Pharmaceuticals doses first patient in Phase 2 trial of REC-3964

    10/22/2024 - 08:28am
dynamic_feed Breaking News